Vicente AM, Ballensiefen W, Jönsson JI. How personalised medicine will transform healthcare by 2030: the ICPerMed vision. J Transl Med. 2020;18:180. https://doi.org/10.1186/s12967-020-02316-w.
Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat Rev Genet. 2019;20:109–27.
Ganesan A. Epigenetic drug discovery: a success story for cofactor interference. Philos Trans R Soc B Biol Sci. 2018;373:20170069. https://doi.org/10.1098/rstb.2017.0069.
Cossío FP, Esteller M, Berdasco M. Towards a more precise therapy in cancer: exploring epigenetic complexity. Curr Opin Chem Biol. 2020;57:41–9.
Lamb YN, Dhillon S. Epi proColon® 2.0 CE: a blood-based screening test for colorectal cancer. Mol Diagn Ther. 2017;21:225–32.
Ned RM, Melillo S, Marrone M. Fecal DNA testing for Colorectal Cancer Screening: the ColoSureTM test. PLoS Curr. 2011;3:RRN1220.
Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003.
Delgado-Morales R, Agís-Balboa RC, Esteller M, Berdasco M. Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. Clin Epigenetics. 2017;9:67.
Ai S, Xu Q, Hu Y, Song C, Guo J, Shen L, et al. Hypomethylation of SNCA in blood of patients with sporadic Parkinson’s disease. J Neurol Sci. 2014;337:123–8.
Iwata A, Nagata K, Hatsuta H, Takuma H, Bundo M, Iwamoto K, et al. Altered CpG methylation in sporadic Alzheimer’s disease is associated with APP and MAPT dysregulation. Hum Mol Genet. 2014;23:648–56.
Sanchez-Mut JV, Heyn H, Silva BA, Dixsaut L, Garcia-Esparcia P, Vidal E, et al. PM20D1 is a quantitative trait locus associated with Alzheimer’s disease. Nat Med. 2018;24:598–603.
Alegría-Torres JA, Baccarelli A, Bollati V. Epigenetics and lifestyle. Epigenomics. 2011;3:267–77.
Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012;15:405–11.
Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81–6.
Huang JY, King NB. Epigenetics changes nothing: what a new scientific field does and does not mean for ethics and social justice. Public Health Ethics. 2018;11:69–81.
Chiapperino L. Epigenetics: ethics, politics, biosociality. Br Med Bull. 2018;128:49–60.
Joly Y, So D, Saulnier K, Dyke SOM. Epigenetics ELSI: darker than you think? Trends Genet. 2016;32:591–2.
Rothstein MA, Cai Y, Marchant GE. The ghost in our genes: legal and ethical implications of epigenetics. Health Matrix Clevel. 2009;19:1–62.
Department of Health, Education and W, National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent. 2014;81:4–13. http://www.ncbi.nlm.nih.gov/pubmed/25951677.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583.
Luo C, Hajkova P, Ecker JR. Dynamic DNA methylation: in the right place at the right time. Science. 2018;361:1336–40.
Dyke SOM, Cheung WA, Joly Y, Ammerpohl O, Lutsik P, Rothstein MA, et al. Epigenome data release: a participant-centered approach to privacy protection. Genome Biol. 2015;16:142.
Satterlee JS, Chadwick LH, Tyson FL, McAllister K, Beaver J, Birnbaum L, et al. The NIH common fund/roadmap epigenomics program: successes of a comprehensive consortium. Sci Adv. 2019;5:eaaw6507. https://doi.org/10.1126/sciadv.aaw6507.
Stunnenberg HG, International Human Epigenome Consortium, Hirst M. The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery. Cell. 2016;167:1897.
Dyke SOM, Saulnier KM, Dupras C, Webster AP, Maschke K, Rothstein M, et al. Points-to-consider on the return of results in epigenetic research. Genome Med. 2019;11:31. https://doi.org/10.1186/s13073-019-0646-6.
Lautenbach DM, Christensen KD, Sparks JA, Green RC. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genom Hum Genet. 2013;14:491–513. https://doi.org/10.1146/annurev-genom-092010-110722.
Rothstein MA, Cai Y, Marchant GE. Ethical implications of epigenetics research. Nat Rev Genet. 2009;10:224–224.
Paul B, Barnes S, Demark-Wahnefried W, Morrow C, Salvador C, Skibola C, et al. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics. 2015;7:112.
Teschendorff AE, Yang Z, Wong A, Pipinikas CP, Jiao Y, Jones A, et al. Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer. JAMA Oncol. 2015;1:476. https://doi.org/10.1001/jamaoncol.2015.1053.
Kunysz M, Mora-Janiszewska O, Darmochwał-Kolarz D. Epigenetic modifications associated with exposure to endocrine disrupting chemicals in patients with gestational diabetes mellitus. Int J Mol Sci. 2021;22:4693.
Horsthemke B. A critical view on transgenerational epigenetic inheritance in humans. Nat Commun. 2018;9:2973.
Beauchamp TL. Informed consent: its history, meaning, and present challenges. Cambridge Q Healthc Ethics. 2011;20:515–23.
Bradbury AR, Patrick-Miller L, Domchek S. Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing. Genet Med. 2015;17:97–8.
Alblas M, Schermer M, Vergouwe Y, Bolt I. Autonomy challenges in epigenetic risk-stratified cancer screening: how can patient decision aids support informed consent? J Personal Med. 2019;9:14.
Bunnik EM, Janssens ACJW, Schermer MHN. A tiered-layered-staged model for informed consent in personal genome testing. Eur J Hum Genet. 2013;21:596–601.
Bunnik EM, Janssens ACJW, Schermer MHN. Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent. Bioethics. 2014;28:343–51. https://doi.org/10.1111/bioe.12004.
Joseph-Williams N, Newcombe R, Politi M, Durand M-A, Sivell S, Stacey D, et al. Toward minimum standards for certifying patient decision aids. Med Decis Mak. 2014;34:699–710. https://doi.org/10.1177/0272989X13501721.
Clayton EW, Evans BJ, Hazel JW, Rothstein MA. The law of genetic privacy: applications, implications, and limitations. J Law Biosci. 2019;6:1–36.
Johnson SB, Slade I, Giubilini A, Graham M. Rethinking the ethical principles of genomic medicine services. Eur J Hum Genet. 2020;28:147–54.
Widschwendter M, Jones A, Evans I, Reisel D, Dillner J, Sundström K, et al. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2018;15:292–309.
Erlich Y, Narayanan A. Routes for breaching and protecting genetic privacy. Nat Rev Genet. 2014;15:409–21.
Dupras C, Saulnier KM, Joly Y. Epigenetics, ethics, law and society: a multidisciplinary review of descriptive, instrumental, dialectical and reflexive analyses. Soc Stud Sci. 2019;49:785–810.
Thomas CR. Epigenetics and child psychiatry: ethical and legal issues. Behav Sci Law. 2015;33:644–52.
Erwin C. Ethical issues raised by epigenetic testing for alcohol, tobacco, and cannabis. Behav Sci Law. 2015;33:662–74.
Joly Y, Dyke SO, Cheung WA, Rothstein MA, Pastinen T. Risk of re-identification of epigenetic methylation data: a more nuanced response is needed. Clin Epigenetics. 2015;7:45.
Philibert RA, Terry N, Erwin C, Philibert WJ, Beach SR, Brody GH. Methylation array data can simultaneously identify individuals and convey protected health information: an unrecognized ethical concern. Clin Epigenetics. 2014;6:28.
Juengst ET, Fishman JR, McGowan ML, Settersten RA. Serving epigenetics before its time. Trends Genet. 2014;30:427–9.
Schadt EE, Woo S, Hao K. Bayesian method to predict individual SNP genotypes from gene expression data. Nat Genet. 2012;44:603–8.
Heijmans BT, Mill J. Commentary: the seven plagues of epigenetic epidemiology. Int J Epidemiol. 2012;41:74–8.
Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74.
Zhang Y, Elgizouli M, Schöttker B, Holleczek B, Nieters A, Brenner H. Smoking-associated DNA methylation markers predict lung cancer incidence. Clin Epigenetics. 2016;8:127.
Fasanelli F, Baglietto L, Ponzi E, Guida F, Campanella G, Johansson M, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun. 2015;6:10192.
Portilla-Fernández E, Hwang S-J, Wilson R, Maddock J, Hill WD, Teumer A, et al. Meta-analysis of epigenome-wide association studies of carotid intima-media thickness. Eur J Epidemiol. 2021. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34091768.
Bolt I, Bunnik EM, Tromp K, Pashayan N, Widschwendter M, de Beaufort I. Prevention in the age of personal responsibility: epigenetic risk-predictive screening for female cancers as a case study. J Med Ethics. 2020. http://www.ncbi.nlm.nih.gov/pubmed/33208479.
Hedlund M. Epigenetic responsibility. Med Stud. 2012;3:171–83. https://doi.org/10.1007/s12376-011-0072-6.
Chiapperino L, Testa G. The epigenomic self in personalized medicine: between responsibility and empowerment. Sociol Rev Monogr. 2016;64:203–20. https://doi.org/10.1002/2059-7932.12021.
Hollands GJ, French DP, Griffin SJ, Prevost AT, Sutton S, King S, et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016;352:i1102.
Sørensen K, Van den Broucke S, Fullam J, Doyle G, Pelikan J, Slonska Z, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012;12:80.
Tajdar D, Lühmann D, Fertmann R, Steinberg T, van den Bussche H, Scherer M, et al. Low health literacy is associated with higher risk of type 2 diabetes: a cross-sectional study in Germany. BMC Public Health. 2021;21:510.
Lo LLH, Suen YN, Chan SKW, Sum MY, Charlton C, Hui CLM, et al. Sociodemographic correlates of public stigma about mental illness: a population study on Hong Kong’s Chinese population. BMC Psychiatry. 2021;21:274.
Galvin AM, Garg A, Matthes S, Thompson EL. Utilizing a multidimensional health literacy framework to assess cervical cancer screening nonadherence. Health Educ Behav. 2021;10901981211001852. Available from http://www.ncbi.nlm.nih.gov/pubmed/33829878.
Babicz MA, Woods SP, Matchanova A, Medina LD, Podell K, Walker RL, et al. How did individual differences in neurocognition and health literacy influence the initial uptake and use of health-related information about COVID-19? J Clin Exp Neuropsychol. 2021;43:1–17.
Garcia-Codina O, Juvinyà-Canal D, Amil-Bujan P, Bertran-Noguer C, González-Mestre MA, Masachs-Fatjo E, et al. Determinants of health literacy in the general population: results of the Catalan health survey. BMC Public Health. 2019;19:1122. https://doi.org/10.1186/s12889-019-7381-1.
Sørensen K, Pelikan JM, Röthlin F, Ganahl K, Slonska Z, Doyle G, et al. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015;25:1053–8.
Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci. 2008;105:17046–9. https://doi.org/10.1073/pnas.0806560105.
Dwyer J. How to connect bioethics and environmental ethics: health, sustainability, and justice. Bioethics. 2009;23:497–502. https://doi.org/10.1111/j.1467-8519.2009.01759.x.
Fletcher J. Principles of biomedical ethics. By Tom L. Beauchamp and James F. Childress . New York, Oxford University Press, 1979. 314 pp. $13.95. $7.95 (paper). Theol Today. 1980;36:595–6. https://doi.org/10.1177/004057368003600423.
Dupras C, Ravitsky V, Williams-Jones B. Epigenetics and the environment in bioethics. Bioethics. 2014;28:327–34. https://doi.org/10.1111/j.1467-8519.2012.02007.x.
Chiapperino L. Luck and the responsibilities to protect one’s epigenome. J Responsible Innov. 2020;7:S86-106. https://doi.org/10.1080/23299460.2020.1842658.
Dupras C, Ravitsky V. The ambiguous nature of epigenetic responsibility. J Med Ethics. 2016;42:534–41.
Breton CV, Landon R, Kahn LG, Enlow MB, Peterson AK, Bastain T, et al. Exploring the evidence for epigenetic regulation of environmental influences on child health across generations. Commun Biol. 2021;4:769.
Sundar IK, Rahman I. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer. Am J Physiol Lung Cell Mol Physiol. 2016;311:L1245–58.
Walton E, Relton CL, Caramaschi D. Using openly accessible resources to strengthen causal inference in epigenetic epidemiology of neurodevelopment and mental health. Genes (Basel). 2019;10:193.
Rauschert S, Raubenheimer K, Melton PE, Huang RC. Machine learning and clinical epigenetics: a review of challenges for diagnosis and classification. Clin Epigenetics. 2020;12:51. https://doi.org/10.1186/s13148-020-00842-4.
Cazaly E, Saad J, Wang W, Heckman C, Ollikainen M, Tang J. Making sense of the epigenome using data integration approaches. Front Pharmacol. 2019. https://doi.org/10.3389/fphar.2019.00126/full.
Nakamura M, Gao Y, Dominguez AA, Qi LS. CRISPR technologies for precise epigenome editing. Nat Cell Biol. 2021;23:11–22.
Cano-Rodriguez D, Gjaltema RAF, Jilderda LJ, Jellema P, Dokter-Fokkens J, Ruiters MHJ, et al. Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Nat Commun. 2016;7:12284.
Carter B, Zhao K. The epigenetic basis of cellular heterogeneity. Nat Rev Genet. 2021;22:235–50.
Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell. 2010;19:698–711.
Dupras C, Ravitsky V. Epigenetics in the neoliberal “regime of truth.” Hastings Cent Rep. 2016;46:26–35.
Savard J. Personalised medicine: a critique on the future of health care. J Bioeth Inq. 2013;10:197–203. https://doi.org/10.1007/s11673-013-9429-8.
Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Personal Med. 2015;12:43–51. https://doi.org/10.2217/pme.14.65.
Abettan C, Welie JVM. The impact of twenty-first century personalized medicine versus twenty-first century medicine’s impact on personalization. Philos Ethics Humanit Med. 2020;15:11. https://doi.org/10.1186/s13010-020-00095-2.
Redolat R, Mesa-Gresa P, Sampedro-Piquero P, Cutuli D. Editorial: environmental enrichment as a treatment? Epigenetic mechanisms, challenges and limitations. Front Pharmacol. 2021. https://doi.org/10.3389/fphar.2021.658970/full.
Hannan AJ. Review: environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity. Neuropathol Appl Neurobiol. 2014;40:13–25. https://doi.org/10.1111/nan.12102.
Chiapperino L. Environmental enrichment: an experiment in biosocial intervention. BioSocieties. 2021;16:41–69. https://doi.org/10.1057/s41292-019-00181-5.
Braun B. Biopolitics and the molecularization of life. Cult Geogr. 2007;14:6–28. https://doi.org/10.1177/1474474007072817.
Clarke AE. Biomedicalization. Wiley Blackwell encycl heal illness, behav soc. Chichester: Wiley; 2014. p. 137–42. https://doi.org/10.1002/9781118410868.wbehibs083.
Santaló J. Epigenetics: hope against genetic determinism. In: Blanco CC, editor. Epigenetics assist reprod an introd guid. Boca Raton: CRC Press; 2018. p. 183–8.